CN1872111A - Medication for treating cardiovascular diseases and cerebrovascular disease - Google Patents
Medication for treating cardiovascular diseases and cerebrovascular disease Download PDFInfo
- Publication number
- CN1872111A CN1872111A CN 200510013615 CN200510013615A CN1872111A CN 1872111 A CN1872111 A CN 1872111A CN 200510013615 CN200510013615 CN 200510013615 CN 200510013615 A CN200510013615 A CN 200510013615A CN 1872111 A CN1872111 A CN 1872111A
- Authority
- CN
- China
- Prior art keywords
- adjuvant
- drop pill
- medicine
- folium ginkgo
- radix ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 92
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 18
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 14
- 229940079593 drug Drugs 0.000 title description 27
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 13
- 239000006187 pill Substances 0.000 claims description 122
- 239000002671 adjuvant Substances 0.000 claims description 76
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 56
- 235000011201 Ginkgo Nutrition 0.000 claims description 55
- 239000000203 mixture Substances 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 45
- 235000020710 ginseng extract Nutrition 0.000 claims description 43
- 239000000341 volatile oil Substances 0.000 claims description 41
- 238000002360 preparation method Methods 0.000 claims description 38
- 239000000758 substrate Substances 0.000 claims description 35
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 31
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 30
- 235000010447 xylitol Nutrition 0.000 claims description 30
- 239000000811 xylitol Substances 0.000 claims description 30
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 30
- 229960002675 xylitol Drugs 0.000 claims description 30
- 229920002472 Starch Polymers 0.000 claims description 29
- 239000008107 starch Substances 0.000 claims description 29
- 235000019698 starch Nutrition 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 23
- 229940057995 liquid paraffin Drugs 0.000 claims description 22
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 20
- 239000008101 lactose Substances 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 15
- 235000010489 acacia gum Nutrition 0.000 claims description 13
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 238000002844 melting Methods 0.000 claims description 10
- 230000008018 melting Effects 0.000 claims description 10
- 229920002545 silicone oil Polymers 0.000 claims description 10
- 238000009413 insulation Methods 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- -1 hydroxypropyl Chemical group 0.000 claims description 5
- 229940032147 starch Drugs 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 239000002826 coolant Substances 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 235000010981 methylcellulose Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000000638 solvent extraction Methods 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 241000218628 Ginkgo Species 0.000 claims 9
- 230000008901 benefit Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 244000194101 Ginkgo biloba Species 0.000 description 49
- 239000012530 fluid Substances 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 238000001035 drying Methods 0.000 description 20
- 239000012188 paraffin wax Substances 0.000 description 18
- 230000004927 fusion Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 238000009472 formulation Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000006225 natural substrate Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 244000286663 Ficus elastica Species 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- 244000275012 Sesbania cannabina Species 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 229960001375 lactose Drugs 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229960001947 tripalmitin Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating cardiovascular and cerebrovascular diseases is disclosed. Its advantages are high natural level and safety and low toxic by-effect.
Description
Technical field
The present invention relates to field of medicaments, particularly, relating to Chinese medicine is medicine of the treatment cardiovascular and cerebrovascular disease made of raw material and preparation method thereof.
Background technology
Folium Ginkgo is the leaf of Ginkgoaceae Ginkgo plant Ginkgo biloba (Ginkgobiloba L.).Contain flavonoid (kind surplus in the of about 20), terpenoid, phenols, effective ingredient such as healthy trace elements with household and 17 seed amino acids have and reduce serum cholesterol, coronary blood flow increasing, improve cerebral blood circulation, remove smooth muscle spasm, lax bronchus and pharmacological action such as antibacterial.Not only be applied to treat cardiovascular and cerebrovascular disease clinically, and nervous system, respiratory system etc. is also had good effect.Scientist such as France and Germany is verified, and Folium Ginkgo extract is all having significant curative effect aspect treatment cerebral ischemia, brain injury sequela and the defying age.
In recent years, along with people go deep into the further of Semen Ginkgo research, the report that Semen Ginkgo and other medical material compatibilities use day by day increases.[the early stage Fibrotic preliminary study of compound gingko leaf preparation treatment chronic hepatitis B such as Li Wei, China combination of Chinese and Western medicine magazine .1995,15 (10): 593] report, select for use Folium Ginkgo, the Radix Astragali, Radix Scutellariae, Rhizoma Polygoni Cuspidati, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Carapax Trionycis etc. to make electuary, the early stage patients with liver fibrosis of treatment chronic type b delay property and active hepatitis, the result shows that the hepatic fibrosis process is eased, and the early stage fibrosis of chronic hepatitis B is all had curative effect preferably.[the development of compound gingkgo pulse invigorating capsule such as Chen Dengfeng, Chinese Hospitals pharmaceutical journal .2000,20 (3): 146-147] report, adopt Folium Ginkgo, Radix Notoginseng, Radix Salviae Miltiorrhizae, the Radix Astragali and Rhizoma Chuanxiong etc. to make the compound gingkgo pulse invigorating capsule, effect with blood circulation promoting and blood stasis dispelling, clinical prevention and the treatment that is used for cardiovascular and cerebrovascular disease obtained good effect.Liu Xiaotian etc. [compound folium ginkgo tincture treatment burn 38 examples are observed Zhejiang combination of Chinese and Western medicine magazine .1998,8 (6): 391] have reported that employing Folium Ginkgo, Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendri, Camphora etc. make tincture, and treatment burn 38 examples have obtained satisfied curative effect.
The synthetic chemical substance that modern medicine is commonly used has spreaded all over each corner of human lives, chemical synthetic drug becomes the main flow of medicine, yet, appearance along with multiple difficult serious symptom miscellaneous diseases, western medical treatment presents imperfect, the human lives and the healthy reality and the up-to-date successes achieved in research have all proposed query to this situation, particularly along with the continuous appearance of chemical drugs toxic and side effects, the change of spectrum of disease and conversion of medical, make modern medicine be subjected to unprecedented challenge, and people also place hope in the application and development of traditional medicine on gradually.Advocate back to nature, pay attention to plant amedica use, hanker after traditional remedies, the trend of advocating natural drug forms, making full use of natural materials is human best selections.Dropping pill formulation be a kind of have efficient, quick-acting new medicine preparations, it has overcome the shortcoming and deficiency of Chinese medicine preparation in the past, but present dropping pill formulation generally faces following problem: 1, drop pill adjuvant pure natural degree is not high: at present, drop pill substrate adjuvant mostly is synthetic, natural degree is lower, the searching of new alternative substrate adjuvant, the searching of the alternative substrate adjuvant that particularly natural degree is high and preparation technology thereof determine, it is again very difficult thing, because the required preparation condition of at present common possible natural substrates adjuvant succedaneum is very harsh, it all is to influence the key that drop pill prepares molding that adjuvant temperature and drop pill thereof drip the system condition.The too high then viscosity of adjuvant melt temperature is low, and poor plasticity is though the adjuvant melt temperature is crossed lowplastcity by force, but drop pill has shortcomings such as easily sticking ball, distortion, therefore, seek pure natural degree height, and the adjuvant that is suitable for substituting existing drop pill substrate is a very job of hardships.2, the drop pill outlet encounters problems: along with expanding economy, more and more internationalize in market, China is also just making great efforts to adapt to this trend, present Chinese medicine dripping pills preparation as health food, successful export to many countries, but also face many problems at present, because different countries is different to the approval of the selected adjuvant of Chinese medicine dropping pill formulation, especially industrial flourishing Europe, more strict to food adjuvant and medical auxiliary materials, and as the selected chemosynthesis adjuvant (as Polyethylene Glycol) of the dropping pill formulation of health food outlet not in the catalogue of some national food additive, it is very unfavorable that this moves towards the international market to the Chinese medicine dropping pill formulation, becomes the stumbling-block that Chinese medicine enters the international market, therefore, seek the new of one or more, can be particularly important, also very urgent for the substrate adjuvant that the international market is accepted.3, the shortcoming of mouthfeel and onset speed: the mouthfeel of Chinese medicine and preparation thereof is relatively poor to be the big characteristics of one, people when taking some drugs to the frightened of disagreeable taste that medicine had even be better than fear far away to disease, What is more, some patients are because can not overcome the poor taste of Chinese medicine or its preparation or abnormal smells from the patient and abandon the treatment of Chinese medicine, though can improve mouthfeel as medicine being made capsule or sugar coated tablet, reducing stimulates, but disintegration rate prolongs, be unfavorable for the rapid onset of medicine, to some disease, particularly need the disease of the rapid onset of medicine inapplicable.4, the preparation process difficulty of drop pill suitability for industrialized production: in the replacement process of dropping pill formulation adjuvant, determining of the preparation process of its suitability for industrialized production is very difficult something, as the ratio of the melt temperature of substrate adjuvant, the proportioning of dripping system temperature, adjuvant and medicine, dropper bore, condensing agent etc. all are the factors that influence drop pill, therefore, the replacement of substrate and to be suitable for suitability for industrialized production be a job consuming time, as to expend substantial contribution.
In order to change drop pill substrate adjuvant for a long time based on the situation of chemosynthesis adjuvant, it is low to solve the pure natural degree that present drop pill substrate faced, and can not satisfy more and more that people require back to nature, take low toxicity, the problem of the pure natural medical that has no side effect; Also can solve some problems that Chinese medicine preparation, particularly dropping pill formulation are run in exit procedure, strengthen the competitiveness of international market; The present invention has invented the pure Chinese medicine dripping pills preparation that a kind of toxic and side effects is low, evident in efficacy, moderate, adapt to industrialized great production by a large amount of tests and the research of preparation process.
Summary of the invention
The medicine that the purpose of this invention is to provide a kind of treatment cardiovascular and cerebrovascular disease with new type natural substrate adjuvant preparation.
Another object of the present invention provides a kind of preparation method for the treatment of the cardiovascular and cerebrovascular diseases medicament preparation.
The present invention is the new pharmacological action that the qi-blood relationship theory learned according to Chinese traditional medicine and modern medicine are found various institutes of Chinese materia medica, according to " symptomatic treatment in acute condition, radical treatment in chronic case ", set upright based on reinforcing, " lead to " and just must not hinder, " benefit " must not be detained, treating both the principal and secondary aspects of a disease.The medicine of producing according to this method has late result again, and finally reaches the healing purpose the existing short term effect of the treatment of coronary heart disease, and generation without any side effects.The selected substrate adjuvant of the present invention is resulting by a large amount of tests, it is little to have molecular weight, soluble in water, and molten diffusing speed is faster, pure natural degree height, toxic and side effects is lower, and can reduce the medicine irritation abnormal smells from the patient, has the oral cavity of improvement acid-base value during the buccal of oral cavity, improve the characteristics of oral cavity smell, the used substrate adjuvant of the present invention is the agent of food sedan-chair flavor, takes that mouthfeel is good, the acceptant characteristics of patient, is the direction of following substrate adjuvant development.
The consumption of drug component of the present invention and the selection of adjuvant thereof also grope to sum up to draw through the inventor in a large number, this medication medication is formed and is comprised: Folium Ginkgo extract 30～90 weight portions, Radix Ginseng extract 1～30 weight portion, Rhizoma Chuanxiong volatile oil 1～50 weight portion, appropriate amount of auxiliary materials, filler adjuvant wherein is selected from the natural adjuvant of following one or more plant origins: sorbitol, xylitol, lactose, maltose, and they contain the water of crystallization chemical compound; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: pregelatinized Starch, carboxymethyl starch, methylcellulose, sodium carboxymethyl cellulose, hydroxypropyl emthylcellulose, arabic gum, alginic acid, dextrin, cyclodextrin, agar, lactose.
Medicine preferred of the present invention is formed and is comprised: Folium Ginkgo extract 40～80 weight portions, Radix Ginseng extract 5～25 weight portions, Rhizoma Chuanxiong volatile oil 10～40 weight portions, appropriate amount of auxiliary materials, filler adjuvant wherein are selected from following one or more the natural adjuvant of plant origin: xylitol, lactose; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: starch, arabic gum.
Best medicine of the present invention is formed and is comprised: Folium Ginkgo extract 60 weight portions, Radix Ginseng extract 15 weight portions, Rhizoma Chuanxiong volatile oil 25 weight portions, appropriate amount of auxiliary materials, filler adjuvant wherein is xylitol and starch, perhaps being lactose and starch, perhaps is xylitol and arabic gum.
Can also also have erythritol in the above-mentioned adjuvant, fructose, D-ribonic acid-gamma lactone, arabitol, trehalose, D-ribose, low melting-point agarose, Lac, Raffinose, glucose, malic acid, citric acid, isomalt, dextran, chitin, sesbania gum, carrageenan, Ficus elastica, Furcellaran, the tragakanta, carrageenin, tamarind gum, pectin, xanthan gum, modified starch, hydroxypropyl starch, methylcellulose, microcrystalline Cellulose, cross-linking sodium carboxymethyl cellulose, hydroxyethylmethyl-cellulose, hydroxyethyl-cellulose, hydroxypropyl cellulose etc.
Can also contain chemosynthesis adjuvant and animal origin adjuvant in the above-mentioned adjuvant, wherein filler comprises phenylglycol, hexadecanol, octadecanol, sodium stearate, tristerin, tripalmitin, carbamide, polyoxyethylene monostearate, polyoxyethylene alkyl ether; Wherein plasticity substrate comprises polyvinylpyrrolidone, crospolyvinylpyrrolidone, carbomer, polyvinyl alcohol, acrylic resin, poloxamer, gelatin.
At ratio of adjuvant molding is found in the sex research, in the combination of xylitol and starch, lactose and starch, xylitol and arabic gum, low melting point substrate adjuvant is 1: 0～1: 1.5 with the ratio of the weight of plasticity substrate adjuvant, be preferably 1: 0.1～1: 0.9, the best is 1: 0.1～1: 0.5.Specific to each combination, xylitol is preferably 1: 0.2 with the ratio of the weight of starch～1: 0.3, and lactose is preferably 1: 0.2 with the ratio of the weight of starch～1: 0.3, and the ratio of the weight of xylitol and arabic gum is preferably 1: 0.2～and 1: 0.4.
Medicine mesostroma adjuvant of the present invention and amount of drug are than can being the scope that allows on the galenic pharmacy, medicine described here can be that crude drug also can be the effective ingredient extract, in order to adapt to industrialized great production, the ratio range of mesostroma adjuvant of the present invention and medicine refers to the weight proportion of adjuvant and drug extract, adjuvant and Folium Ginkgo extract, Radix Ginseng extract, the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.1～1: 1; Preferred adjuvant and Folium Ginkgo extract, Radix Ginseng extract, the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.1～1: 0.6; Best adjuvant and Folium Ginkgo extract, Radix Ginseng extract, the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.2～1: 0.4.
Medicine of the present invention can adopt the preparation of Chinese medicine preparation conventional method.The preparation of effective ingredient of the present invention can be adopted following method: water extraction, decoction and alcohol sedimentation technique, extraction, infusion process, percolation, reflux extraction, continuous backflow extraction method, macroreticular resin absorbing method preparation.For example, these crude drug pulverize mix homogeneously can be made powder takes after mixing it with water; Also can be with these medicines decocting together, the condensed water decocting liquid is made oral liquid then; But, preferably adopt following technology to extract, but this can not limit protection scope of the present invention to raw material in order to make each crude drug of this medicine better bring into play drug effect.
The preparation method of medicine of the present invention is as follows:
(a), get Folium Ginkgo, pulverize or do not pulverize, adopt water extraction, or the organic solvent extraction method, or resin adsorption method, or supercritical fluid extraction, Folium Ginkgo extract;
(b), get Radix Ginseng (or stem, leaf), adopt water extraction, or the organic solvent extraction method, or column adsorption method, Radix Ginseng extract;
(c), get Rhizoma Chuanxiong, pulverize or do not pulverize, adopt hydrodistillation, or supercritical fluid extraction, promptly get volatile oil;
(d), with above-mentioned Folium Ginkgo, Radix Ginseng extract and Rhizoma Chuanxiong volatile oil mix homogeneously, add in the appropriate amount of auxiliary materials, fully mix, heating and melting stirs, insulation, at 45～95 ℃ of temperature following system, dropper bore is 1.0～4.0 millimeters, splash in-20～25 ℃ liquid paraffin, methyl-silicone oil or the vegetable oil, make drop pill, promptly.
In the preferred above-mentioned preparation method step (d), mixture is at 50～115 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, and insulation is 1.1～3.5 millimeters at 60～85 ℃ of temperature following system, dropper bore, splash in 0～18 ℃ the liquid paraffin, methyl-silicone oil, back packing to be dried is made drop pill, promptly.
In the best above-mentioned preparation method step (d), mixture is at 67 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, insulation, at 67 ℃ of temperature following system, dropper bore is 1.2～2.5 millimeters, splash in 0 ℃ the methyl-silicone oil, to the greatest extent and wipe liquid coolant, back packing to be dried the drop pill drop that forms, make drop pill, promptly.
More than form when producing and to increase or to reduce according to corresponding ratio, as large-scale production can be unit with kilogram or with the ton, small-scale production can be unit with the gram also, and weight can increase or reduce, but the crude drug material weight proportion constant rate between each composition.
More than each single medicinal material, especially adjuvant drug, messenger drug or adjuvant drug and messenger drug in forming, can be replaced by suitable Chinese medicine individually or simultaneously with the identical property of medicine, effect, it is constant to replace back Chinese medicine preparation and drug effect thereof.
Medicine of the present invention can be determined usage and dosage according to patient's situation in use, but every day 1-3 time, and every day, each crude drug consumption was as the criterion with the state-promulgated pharmacopoeia dosage, was no more than the pharmacopeia ormal weight.
The drop pill that the present invention is prepared, conventional drop pill advantage is simple as preparing except having, steady quality, can make liquid medicine solidification, convenient drug administration, efficient, quick-acting, its biggest advantage is:
1, the selected adjuvant pure natural of the present invention degree height: the substrate adjuvant that employed substrate adjuvant derives from natural plants or originates based on natural plants among the present invention, selected substrate adjuvant is xylitol and starch or lactose and starch or xylitol and arabic gum, this substrate adjuvant has pure natural degree height, toxic and side effects is low, mouthfeel is good, dissolve scattered time limit is short, rapid-action, it is a kind of new medium adjuvant, can be used for substituting present chemosynthesis substrate adjuvant, the drop pill made from this kind adjuvant, it is low to solve the pure natural degree that present drop pill substrate faced, and more and more can not satisfy people and require back to nature, take low toxicity, the problem of the pure natural medical that has no side effect.
2, some problems in the outlet of solution Chinese medicine: medicine of the present invention also can solve Chinese medicine preparation, some problems of in exit procedure, being run into of dropping pill formulation particularly, solve because different countries, especially the European countries of industry prosperity are to the difference identification of the selected adjuvant of Chinese medicine dropping pill formulation, overcome as the selected adjuvant Polyethylene Glycol of the dropping pill formulation of the health food outlet defective in some national food additive catalogue not, improve the Chinese medicine dripping pills preparation and move towards the international market, strengthen the competitiveness of international market.
3, solve the relatively poor problem of drop pill taste and further improve drug effect speed (dissolve scattered time limit): the medicinal dropping ball made from this kind substrate adjuvant of the present invention, can improve Chinese medicine preparation, the particularly present not good shortcoming of dropping pill formulation taste, improve mouthfeel, more easy for patients to accept, and the drop pill that adopts the selected adjuvant of medicine of the present invention to make has shorter dissolve scattered time limit, makes drug effect faster.
4, higher safety and solve some problems in the drop pill storage process: the selected substrate of the present invention is not only additive, nutrient commonly used in the food industry, and can do medicinal, but do not see that it uses as the drug matrices adjuvant, therefore, with regard to substrate, be perfectly safe, have no side effect, a large amount of evidences, the drop pill that this adjuvant is made can reduce effective ingredient separating out in storage process, the sticking ball of drop pill, easy shortcomings such as moisture absorption deliquescing, but the big production of suitability for industrialized.
In order to understand the present invention better, dissolve scattered time limit, weight differential, drop pill soft durometer, the drop pill with FUFANG DANSHEN DIWAN glues test explanation advantages of the present invention such as ball below.
Test example 1: dissolve scattered time limit contrast experiment example
In vitro tests
According to the new substrate Yixintong of the present invention drop pill of the tripartite method preparation of embodiment,, investigate its good releasing effect by indexs such as mensuration dissolve scattered time limits.
1. test medication: the new substrate Yixintong of the present invention drop pill.
2. method and result:
Dissolve scattered time limit: by " method is measured result such as table 1 under this item of Chinese pharmacopoeia.
The dissolve scattered time limit of the Yixintong drop pill that three batches in table 1 is made with the new medium adjuvant, weight differential are relatively
| 0 month | January | February | March | June | December | 18 months | ||
| 1 batch | Criterion | The result | ||||||
| Weight differential (± 15%) | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | |
| Dissolve scattered time limit | 4′45″ | 4′45″ | 4′46″ | 4′46″ | 4′50″ | 4′50″ | 4′51″ | |
| 2 batches | Weight differential (± 15%) | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% |
| Dissolve scattered time limit | 4′44″ | 4′45″ | 4′45″ | 4′45″ | 4′45″ | 4′46″ | 4′49″ | |
| 3 batches | Weight differential (± 15%) | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% | All in 10% |
| Dissolve scattered time limit | 4′44″ | 4′44″ | 4′45″ | 4′45″ | 4′45″ | 4′47″ | 4′49″ | |
Test data shows, different all being controlled in the pharmacopeia prescribed limit of dissolve scattered time limit, the ball method of double differences of new substrate Yixintong drop pill.Result of the test explanation, the molten diffusing speed of the Yixintong drop pill made from novel adjuvant is faster, is more conducive to medicine and plays a role in the shortest time; Different being controlled in the pharmacopeia prescribed limit of the ball method of double differences of new substrate Yixintong drop pill illustrates that this natural substrates adjuvant is used to prepare drop pill, and can use in industrialization.
Test example 2: the new substrate Yixintong of the present invention drop pill soft durometer, the sticking ball comparative observation of drop pill
According to 3 batches of the new substrate Yixintong of the present invention drop pill of embodiment 1 method preparation, be loaded in the porcelain vase respectively, and use the bottle stopper good seal.Putting it into the bottom has in the exsiccator of saturated Nacl (humidity 75%) solution, exsiccator is put into 40 ℃ of drying baker of constant temperature again, and timing sampling is observed situations such as drop pill soft durometer, the sticking ball of drop pill, the results are shown in Table 2.
Table 2: three batches of Yixintong drop pill character observations made from the new medium adjuvant relatively
| 0 month | January | February | March | June | December | 18 months | ||
| Criterion | The result | |||||||
| 1 batch | Sticking ball | Not sticking | Not sticking | Not sticking | Not sticking | Not sticking | Not sticking | Sticking slightly |
| Soft durometer | Firmly | Firmly | Firmly | Firmly | Firmly | Firmly | Hard slightly | |
| 2 batches | Sticking ball | Not sticking | Not sticking | Not sticking | Not sticking | Not sticking | Not sticking | Sticking slightly |
| Soft durometer | Firmly | Firmly | Firmly | Firmly | Firmly | Firmly | Hard slightly | |
| 3 batches | Sticking ball | Not sticking | Not sticking | Not sticking | Not sticking | Sticking | Sticking slightly | Sticking slightly |
| Soft durometer | Firmly | Firmly | Firmly | Firmly | Firmly | Firmly | Hard slightly |
Test data shows that new substrate Yixintong drop pill soft durometer changes and the sticking ball of drop pill changes little.Result of the test illustrates that the alternative present chemosynthesis adjuvant of this natural substrates adjuvant is used for the preparation of drop pill, but suitability for industrialized production.
The specific embodiment
Below in conjunction with embodiment the present invention is done step explanation, following each embodiment only is used to the present invention is described and is not limitation of the present invention.
Embodiment one
The preparation of Folium Ginkgo extract: get the 1000g Folium Ginkgo and pulverize, measure acetone with 5 times: water (70: 30) mixed liquor heating extraction 2 times, each 2 hours, temperature was 50～60 ℃, and merge extractive liquid, filters, and concentrating under reduced pressure becomes Folium Ginkgo extract 280g;
The preparation of Radix Ginseng extract: get Radix Ginseng section 100g, add 8 times of water gagings, extract 2 times, each 3 hours, merge extractive liquid, concentrated, and is concentrated into every 5ml and contains the 1g ginseng crude drug, gets Radix Ginseng extract 40g;
Get Rhizoma Chuanxiong, pulverize, adopt hydrodistillation, get Rhizoma Chuanxiong volatile oil 80g.
Embodiment two
The preparation of Folium Ginkgo extract: get Folium Ginkgo and pulverize, add 5 times of amount 65% alcohol reflux 2 times, each 2 hours, temperature was 60 ℃, and merge extractive liquid, filters, and concentrating under reduced pressure reclaims ethanol and gets Folium Ginkgo extract 280g;
The preparation of Radix Ginseng extract: get the Radix Ginseng section, add 8 times of amount 70% ethanol, extract 2 times, each 3 hours, merge extractive liquid, reclaimed ethanol, is concentrated into every 5ml and contains the 1g ginseng crude drug, gets Radix Ginseng extract 40g;
Get Rhizoma Chuanxiong, pulverize, adopt hydrodistillation, get Rhizoma Chuanxiong volatile oil 80g.
Embodiment three
Getting the 21.25g xylitol mixes with 4.25g starch, the Folium Ginkgo extract that adding obtains according to embodiment 1 method, Radix Ginseng extract, Rhizoma Chuanxiong volatile oil be 7.5g altogether, Folium Ginkgo extract wherein: Radix Ginseng extract: Rhizoma Chuanxiong volatile oil is 12: 3: 5, fully mix, mixture is at 67 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, insulation is 1.2～2.5 millimeters at 67 ℃ of temperature following system, dropper bore, splashes in 0 ℃ the methyl-silicone oil, make 1000, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried, promptly.
Embodiment four
It is standby to get Folium Ginkgo extract 3g, the Radix Ginseng extract 3g, the Rhizoma Chuanxiong volatile oil 1g that obtain according to embodiment method 2;
To lactose 19.6g, add above-mentioned Folium Ginkgo extract in the mixed compound of starch 5.9g, Radix Ginseng extract, Rhizoma Chuanxiong volatile oil, fully mix, mixture is at 67 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, puts in the surge drum of drop pill machine insulation, in following system of 67 ℃ of temperature, surge drum water dropper gauge inner-diameter is 1.2 millimeters, and external diameter is 4.0 millimeters, and adjusting a distance is 8cm, the speed of dripping with 30 droplets/minute at the uniform velocity splashes in 0 ℃ the methyl-silicone oil, make 1000, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried, make drop pill, promptly.
Embodiment five
Get the mixture of xylitol 18.2g and arabic gum 7.3g, add and get Folium Ginkgo extract 4.5g, Radix Ginseng extract 0.5g, the Rhizoma Chuanxiong volatile oil 2.5g that obtains according to embodiment method 2, mixture is at 60～85 ℃ of heating and meltings, put in the surge drum of drop pill machine, system is dripped in 60～66 ℃ of insulations, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 25cm is 20 ± 2 ℃, and the temperature of bottom 35cm is 2 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment six
Get sorbitol 25.5, Furcellaran 5.5g, heat fused, add and get Folium Ginkgo extract 4g, Radix Ginseng extract 2.5g, the Rhizoma Chuanxiong volatile oil 4g that obtains according to embodiment method 1, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 30 minutes, surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 10cm is 10 ± 2 ℃, and the temperature of bottom 40cm is-5 ± 1 ℃) in the liquid Paraffin condensed fluid with 45 droplets/minute the speed of dripping apart from being 15cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment seven
Get lactose 10.3g, carboxymethyl starch 3.1g, Lac 1.5g, heat fused, Folium Ginkgo extract 0.8g, Radix Ginseng extract 1.1g, Rhizoma Chuanxiong volatile oil 0.2g that adding obtains according to embodiment method 2, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 105 ℃ are incubated 40 minutes, surge drum water dropper gauge inner-diameter is 2.5 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 40cm is 45 ± 2 ℃, and the temperature of bottom 35cm is 5 ± 1 ℃) in the liquid Paraffin condensed fluid with 40 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment eight
Get isomalt 5.0g, xylitol 40g, methylcellulose 2.5g, heat fused, Folium Ginkgo extract 05g, Radix Ginseng extract 5g, Rhizoma Chuanxiong volatile oil 5g that adding obtains according to embodiment method 2, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 45cm is 25 ± 2 ℃, and the temperature of bottom 40cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 3cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make drop pill, promptly.
Embodiment nine
Get Folium Ginkgo extract 4g, the Radix Ginseng extract 0.5g, the Rhizoma Chuanxiong volatile oil 1g that obtain according to embodiment method 2, add the 15ml dehydrated alcohol, after the slight fever dissolving, add in 20.2g lactose, the 5.5g erythritol fused solution, mix, volatilize ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment ten
Get Folium Ginkgo extract 8g, the Radix Ginseng extract 2.5g, the Rhizoma Chuanxiong volatile oil 1g that obtain according to embodiment method 2, add the 15ml dehydrated alcohol, after the slight fever dissolving, add in 35.0g Raffinose, the arabic gum 1.5g fused solution, mix, volatilize ethanol, put in the surge drum of drop pill machine, 72 ℃ are incubated 40 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 7cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 11
Get tripalmitin 7.5g, xylitol 20.5g heat fused, Folium Ginkgo extract 0.3g, Radix Ginseng extract 0.3g, Rhizoma Chuanxiong volatile oil 0.1g that adding obtains according to embodiment method 1, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 30 minutes, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 12
Getting xylitol 20.4g, starch 6.1g mixes, heat fused, Folium Ginkgo extract 4g, Radix Ginseng extract 2g, Rhizoma Chuanxiong volatile oil 1g that adding obtains according to embodiment method 2, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 75 ℃ are incubated 40 minutes, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 8cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 13
Get the mixture of xylitol 17.5g, starch 3.5g, heat fused, Folium Ginkgo extract 2g, Radix Ginseng extract 2g, Rhizoma Chuanxiong volatile oil 4g that adding obtains according to embodiment method 1, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 110 ℃ are incubated 20 minutes, surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 45 ± 2 ℃, and the temperature of bottom 35cm is 3 ± 1 ℃) in the liquid Paraffin condensed fluid with 20 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 14
Getting xylitol 28g, starch 7g mixes, heat fused, Folium Ginkgo extract 8g, Radix Ginseng extract 2g, Rhizoma Chuanxiong volatile oil 1.5g that adding obtains according to embodiment method 1, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 35cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 15
Get the mixture of xylitol 38.6g and starch 3.9g, heat fused, Folium Ginkgo extract 7g, Radix Ginseng extract 3g, Rhizoma Chuanxiong volatile oil 0.5g that adding obtains according to embodiment method 2, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 20 minutes, surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 15cm is 10 ± 2 ℃, and the temperature of bottom 30cm is-3 ± 1 ℃) in the liquid Paraffin condensed fluid with 40 droplets/minute the speed of dripping apart from being 15cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 16
Get the mixture of xylitol 9.4g and starch 5.6g, heat fused, Folium Ginkgo extract 2g, Radix Ginseng extract 2g, Rhizoma Chuanxiong volatile oil 2g that adding obtains according to embodiment method 2, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 25 ± 2 ℃, and the temperature of bottom 35cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 3cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 17
Get Folium Ginkgo extract 1g, the Radix Ginseng extract 2g, the Rhizoma Chuanxiong volatile oil 3g that obtain according to embodiment method 2, add the 15ml dehydrated alcohol, after the slight fever dissolving, add the mixture of xylitol 17g and starch 8.5g, mix, volatilize ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± l ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 18
Get the mixture of 12.25g lactose and 12.25g starch, mix the post-heating fusing, heat fused, Folium Ginkgo extract 2.5g, Radix Ginseng extract 3g, Rhizoma Chuanxiong volatile oil 3.5g that adding obtains according to embodiment method 2 fully stir and make its complete fusion, are uniformly dispersed, put in the surge drum of drop pill machine, 99 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 19
Get the mixture of 28.5g lactose and 6g sesbania gum, mix the post-heating fusing, heat fused, Folium Ginkgo extract 6.5g, Radix Ginseng extract 1.5g, Rhizoma Chuanxiong volatile oil 0.6g that adding obtains according to embodiment method 2 fully stir and make its complete fusion, are uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 35cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 20
Get the mixture of lactose 20.3g, Ficus elastica 3.5g, tragakanta 2.4g, mix the post-heating fusing, heat fused, Folium Ginkgo extract 8.5g, Radix Ginseng extract 2.5g, Rhizoma Chuanxiong volatile oil 2g that adding obtains according to embodiment method 1 fully stir and make its complete fusion, are uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 30cm is 25 ± 2 ℃, and the temperature of bottom 35cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 2cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 21
Get the mixture of 15.7g lactose and 7.05 Furcellaran, mix the post-heating fusing, heat fused, Folium Ginkgo extract 9g, Radix Ginseng extract 3g, Rhizoma Chuanxiong volatile oil 3g that adding obtains according to embodiment method 2 fully stir and make its complete fusion, are uniformly dispersed, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 22
Get the mixture of 24g xylitol and 11g chitin, mix the post-heating fusing, heat fused, Folium Ginkgo extract 10g, Radix Ginseng extract 1.5g, Rhizoma Chuanxiong volatile oil 8g that adding obtains according to embodiment method 1 fully stir and make its complete fusion, are uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 40cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 23
Get the mixture of 14.5g xylitol and 10.5g starch, heat fused, Folium Ginkgo extract 3.5g, Radix Ginseng extract 2.5g, Rhizoma Chuanxiong volatile oil 2.5g that adding obtains according to embodiment method 1, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the methyl-silicone oil condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the methyl-silicone oil on drop pill surface on the skin, place natural drying, make 1000, promptly.
Claims (10)
1, a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that this medicine composition comprises: Folium Ginkgo extract 30～90 weight portions, Radix Ginseng extract 1～30 weight portion, Rhizoma Chuanxiong volatile oil 1～50 weight portion, appropriate amount of auxiliary materials, filler adjuvant wherein is selected from the natural adjuvant of following one or more plant origins: sorbitol, xylitol, lactose, maltose, and they contain the water of crystallization chemical compound; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: pregelatinized Starch, carboxymethyl starch, methylcellulose, sodium carboxymethyl cellulose, hydroxypropyl emthylcellulose, arabic gum, alginic acid, dextrin, cyclodextrin, agar, lactose.
2, the medicine of treatment cardiovascular and cerebrovascular disease as claimed in claim 1, it is characterized in that this medicine composition comprises: Folium Ginkgo extract 40～80 weight portions, Radix Ginseng extract 5～25 weight portions, Rhizoma Chuanxiong volatile oil 10～40 weight portions, appropriate amount of auxiliary materials, filler adjuvant wherein are selected from following one or more the natural adjuvant of plant origin: xylitol, lactose; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: starch, arabic gum.
3, the medicine of treatment cardiovascular and cerebrovascular disease as claimed in claim 2, it is characterized in that this medicine composition comprises: Folium Ginkgo extract 60 weight portions, Radix Ginseng extract 15 weight portions, Rhizoma Chuanxiong volatile oil 25 weight portions, appropriate amount of auxiliary materials, filler adjuvant wherein is xylitol and starch, perhaps being lactose and starch, perhaps is xylitol and arabic gum.
4, the medicine of treatment cardiovascular disease as claimed in claim 3, it is characterized in that described adjuvant is xylitol and starch, xylitol is 1: 0.2～1: 0.3 with the ratio of the weight of starch, perhaps be lactose and starch, lactose is 1: 0.2～1: 0.3 with the ratio of the weight of starch, perhaps be xylitol and arabic gum, the ratio of the weight of xylitol and arabic gum is 1: 0.2～1: 0.4.
5, as the medicine of claim 1,2 or 3 described treatment cardiovascular disease, it is characterized in that adjuvant and Folium Ginkgo extract, Radix Ginseng extract, the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.1～1: 1.
6, the medicine of treatment cardiovascular disease as claimed in claim 5 is characterized in that adjuvant and Folium Ginkgo extract, Radix Ginseng extract, and the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.1～1: 0.6.
7, the medicine of treatment cardiovascular disease as claimed in claim 5 is characterized in that adjuvant and Folium Ginkgo extract, Radix Ginseng extract, and the weight sum ratio of Rhizoma Chuanxiong volatile oil is 1: 0.2～1: 0.4.
8, a kind of preparation method for the treatment of cardiovascular and cerebrovascular diseases medicament comprises the steps:
(a), get Folium Ginkgo, pulverize or do not pulverize, adopt water extraction, or the organic solvent extraction method, or resin adsorption method, or supercritical fluid extraction, Folium Ginkgo extract;
(b), get Radix Ginseng (or stem, leaf), adopt water extraction, or the organic solvent extraction method, or column adsorption method, Radix Ginseng extract;
(c), get Rhizoma Chuanxiong, pulverize or do not pulverize, adopt hydrodistillation, or supercritical fluid extraction, promptly get volatile oil;
(d), with above-mentioned Folium Ginkgo, Radix Ginseng extract and Rhizoma Chuanxiong volatile oil mix homogeneously, add in the appropriate amount of auxiliary materials, fully mix, heating and melting stirs, insulation, at 45～95 ℃ of temperature following system, dropper bore is 1.0～4.0 millimeters, splash in-20～25 ℃ liquid paraffin, methyl-silicone oil or the vegetable oil, make drop pill, promptly.
9, the preparation method of treatment cardiovascular and cerebrovascular diseases medicament as claimed in claim 8, it is characterized in that in the step (d), mixture stirs at 50～115 ℃ of heating and meltings, and mixing time is 10～30 minutes, insulation, at 60～85 ℃ of temperature following system, dropper bore is 1.1～3.5 millimeters, splashes in 0～18 ℃ the liquid paraffin, methyl-silicone oil back packing to be dried, make drop pill, promptly.
10, the preparation method of treatment cardiovascular and cerebrovascular diseases medicament as claimed in claim 8, it is characterized in that in the step (d), mixture stirs at 67 ℃ of heating and meltings, mixing time is 10～30 minutes, insulation is 1.2～2.5 millimeters at 67 ℃ of temperature following system, dropper bore, splashes in 0 ℃ the methyl-silicone oil, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried is made drop pill, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2005100136159A CN1872111B (en) | 2005-06-01 | 2005-06-01 | Medication for treating cardiovascular diseases and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2005100136159A CN1872111B (en) | 2005-06-01 | 2005-06-01 | Medication for treating cardiovascular diseases and cerebrovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1872111A true CN1872111A (en) | 2006-12-06 |
| CN1872111B CN1872111B (en) | 2010-09-29 |
Family
ID=37482821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2005100136159A Expired - Fee Related CN1872111B (en) | 2005-06-01 | 2005-06-01 | Medication for treating cardiovascular diseases and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1872111B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101439058B (en) * | 2007-11-22 | 2011-10-05 | 天津天士力制药股份有限公司 | Compound Chinese medicine gingko granule and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1296060C (en) * | 2002-05-14 | 2007-01-24 | 天津帝士力投资控股集团有限公司 | Compound ginkgo leaf reparation and its making method |
-
2005
- 2005-06-01 CN CN2005100136159A patent/CN1872111B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101439058B (en) * | 2007-11-22 | 2011-10-05 | 天津天士力制药股份有限公司 | Compound Chinese medicine gingko granule and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1872111B (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1626122A (en) | Medication for treating cardiovascular and cerebrovascular diseases | |
| CN1872099B (en) | Medication for treating cardiovascular diseases, and cerebrovascular disease | |
| CN1850167A (en) | Thirsty-relieving blood-sugar-reducing dropping pills and preparing method | |
| CN1686484A (en) | Bastard feverfew throat clearing drip pill and its preparation method | |
| CN1872232B (en) | Composition of medication for curing cerebrovascular disease, and preparation method | |
| CN1872111B (en) | Medication for treating cardiovascular diseases and cerebrovascular disease | |
| CN1872327A (en) | Composition of medicine for treating diarrhea | |
| CN1872250A (en) | Composition of medication for treating headache | |
| CN1626121A (en) | Preparation of Chinese traditional medicine for treating coronary heart disease and angina | |
| CN1626145A (en) | Medication for treating cough | |
| CN1626126A (en) | Drop pills of healthy energy of wrinkled gianthyssop | |
| CN1297255C (en) | Dripping pills for treating high blood fat and its preparing method | |
| CN1626134A (en) | Medication for treating chronic rhinitis and nasal sinuitis | |
| CN1872191B (en) | Drop pills of 'Yixintong' and prepartion method | |
| CN1872285A (en) | Drop pills of Chinese traditional medicine, and preparation method | |
| CN1626147A (en) | Medication for treating coronary heart disease and angina | |
| CN1709461A (en) | Calculus bovis detoxifying dropping pill, and its preparing method | |
| CN1686340A (en) | Gastrodia brain arousing drip pill for nourishing liver and kidney and its preparation method | |
| CN1626132A (en) | Medication for treating obstruction of qi in the chest | |
| CN100512824C (en) | Medication for treating headache | |
| CN1626142A (en) | Medication for treating coronary heart disease and angina | |
| CN100536831C (en) | Medication for treating cardiovascular and cerebrovascular diseases | |
| CN1872260A (en) | Method for preparing drop pills of ageratum vital qi | |
| CN1626129A (en) | Medicine for treating obstruction of qi in the chest and heartache | |
| CN1872231A (en) | Drop pills for treating diabetes, and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100929 Termination date: 20190601 |